Search

Your search keyword '"Verhoef C"' showing total 2,140 results
Start Over Author "Verhoef C"
2,140 results on '"Verhoef C"'

1. Multi-center external validation of an automated method segmenting and differentiating atypical lipomatous tumors from lipomas using radiomics and deep-learning on MRI

Author

Spaanderman, DJ, Hakkesteegt, SN, Hanff, DF, Schut, ARW, Schiphouwer, LM, Vos, M, Messiou, C, Doran, SJ, Jones, RL, Hayes, AJ, Nardo, L, Abdelhafez, YG, Moawad, AW, Elsayes, KM, Lee, S, Link, TM, Niessen, WJ, van Leenders, GJLH, Visser, JJ, Klein, S, Grünhagen, DJ, Verhoef, C, and Starmans, MPA

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Biomedical Imaging, Networking and Information Technology R&D (NITRD), Clinical Research, 4.2 Evaluation of markers and technologies, Good Health and Well Being, Lipomatous tumors, Radiomics, External validation, Prospective validation, Deep learning-based segmentation, Magnetic resonance imaging, Clinical sciences, Health services and systems, Public health
Abstract

BackgroundAs differentiating between lipomas and atypical lipomatous tumors (ALTs) based on imaging is challenging and requires biopsies, radiomics has been proposed to aid the diagnosis. This study aimed to externally and prospectively validate a radiomics model differentiating between lipomas and ALTs on MRI in three large, multi-center cohorts, and extend it with automatic and minimally interactive segmentation methods to increase clinical feasibility.MethodsThree study cohorts were formed, two for external validation containing data from medical centers in the United States (US) collected from 2008 until 2018 and the United Kingdom (UK) collected from 2011 until 2017, and one for prospective validation consisting of data collected from 2020 until 2021 in the Netherlands. Patient characteristics, MDM2 amplification status, and MRI scans were collected. An automatic segmentation method was developed to segment all tumors on T1-weighted MRI scans of the validation cohorts. Segmentations were subsequently quality scored. In case of insufficient quality, an interactive segmentation method was used. Radiomics performance was evaluated for all cohorts and compared to two radiologists.FindingsThe validation cohorts included 150 (54% ALT), 208 (37% ALT), and 86 patients (28% ALT) from the US, UK and NL. Of the 444 cases, 78% were automatically segmented. For 22%, interactive segmentation was necessary due to insufficient quality, with only 3% of all patients requiring manual adjustment. External validation resulted in an AUC of 0.74 (95% CI: 0.66, 0.82) in US data and 0.86 (0.80, 0.92) in UK data. Prospective validation resulted in an AUC of 0.89 (0.83, 0.96). The radiomics model performed similar to the two radiologists (US: 0.79 and 0.76, UK: 0.86 and 0.86, NL: 0.82 and 0.85).InterpretationThe radiomics model extended with automatic and minimally interactive segmentation methods accurately differentiated between lipomas and ALTs in two large, multi-center external cohorts, and in prospective validation, performing similar to expert radiologists, possibly limiting the need for invasive diagnostics.FundingHanarth fonds.

Published
2024

3. The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy

Author

Filipe, W. F., Meyer, Y. M., Buisman, F. E., van den Braak, R. R. J. Coebergh, Galjart, B., Höppener, D. J., Jarnagin, W. R., Kemeny, N. E., Kingham, T. P., Nierop, P. M. H., van der Stok, E. P., Grünhagen, D. J., Vermeulen, P. B., Groot Koerkamp, B., Verhoef, C., and D’Angelica, M. I.

Published
2023
Full Text
View/download PDF

4. Multi-center external validation of an automated method segmenting and differentiating atypical lipomatous tumors from lipomas using radiomics and deep-learning on MRI

Author

Spaanderman, D.J., Hakkesteegt, S.N., Hanff, D.F., Schut, A.R.W., Schiphouwer, L.M., Vos, M., Messiou, C., Doran, S.J., Jones, R.L., Hayes, A.J., Nardo, L., Abdelhafez, Y.G., Moawad, A.W., Elsayes, K.M., Lee, S., Link, T.M., Niessen, W.J., van Leenders, G.J.L.H., Visser, J.J., Klein, S., Grünhagen, D.J., Verhoef, C., and Starmans, M.P.A.

Published
2024
Full Text
View/download PDF

9. Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts

Author

van Geffen, E.G.M., Langhout, J.M.A., Hazen, S.J.A., Sluckin, T.C., van Dieren, S., Beets, G.L., Beets-Tan, R.G.H., Borstlap, W.A.A., Burger, J.W.A., Horsthuis, K., Intven, M.P.W., Aalbers, A.G.J., Havenga, K., Marinelli, A.W.K.S., Melenhorst, J., Nederend, J., Peulen, H.M.U., Rutten, H.J.T., Schreurs, W.H., Tuynman, J.B., Verhoef, C., de Wilt, J.H.W., Marijnen, C.A.M., Tanis, P.J., Kusters, M., and on behalf of the Dutch Snapshot Research Group

Published
2024
Full Text
View/download PDF

20. Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

Author

van den Berg, K., Schaap, D. P., Voogt, E. L. K., Buffart, T. E., Verheul, H. M. W., de Groot, J. W. B., Verhoef, C., Melenhorst, J., Roodhart, J. M. L., de Wilt, J. H. W., van Westreenen, H. L., Aalbers, A. G. J., van ‘t Veer, M., Marijnen, C. A. M., Vincent, J., Simkens, L. H. J., Peters, N. A. J. B., Berbée, M., Werter, I. M., Snaebjornsson, P., Peulen, H. M. U., van Lijnschoten, I. G., Roef, M. J., Nieuwenhuijzen, G. A. P., Bloemen, J. G., Willems, J. M. W. E., Creemers, G. J. M., Nederend, J., Rutten, H. J. T., and Burger, J. W. A.

Published
2022
Full Text
View/download PDF

24. Lever en galwegen

Author

Verhoef, C., de Meijer, V. E., Heineman, E., editor, Heineman, D.J., editor, Lange jr., J.F.M., editor, Blankensteijn, J.D., editor, Boermeester, M.A., editor, Borel Rinkes, I.H.M., editor, Klaase, J.M., editor, Schipper, I.B., editor, Schreurs, W.H., editor, and Wijnen, R.M.H., editor

Published
2021
Full Text
View/download PDF

33. Health-related quality of life (HRQoL) after different axillary treatments in women with breast cancer:a 1-year longitudinal cohort study

Author

Vrancken Peeters, N. J.M.C., Kaplan, Z. L.R., Clarijs, M. E., Mureau, M. A.M., Verhoef, C., van Dalen, T., Husson, O., Koppert, L. B., Vrancken Peeters, N. J.M.C., Kaplan, Z. L.R., Clarijs, M. E., Mureau, M. A.M., Verhoef, C., van Dalen, T., Husson, O., and Koppert, L. B.

Abstract

Purpose: As life expectancy continues to rise, post-treatment health-related quality of life (HRQoL) of breast cancer patients becomes increasingly important. This study examined the one-year longitudinal relation between axillary treatments and physical, psychosocial, and sexual wellbeing and arm symptoms. Methods: Women diagnosed with breast cancer who received different axillary treatments being axilla preserving surgery (APS) with or without axillary radiotherapy or full axillary lymph node dissection (ALND) with or without axillary radiotherapy were included. HRQoL was assessed at baseline, 6- and 12-months postoperatively using the BREAST-Q and the European Organization for Research and Treatment of Cancer QoL Questionnaire Breast Cancer Module (EORTC QLQ-BR23). Mixed regression models were constructed to assess the impact of axillary treatment on HRQoL. HRQoL at baseline was compared to HRQoL at 6- and at 12-months postoperatively. Results: In total, 552 patients were included in the mixed regressions models. Except for ALND with axillary radiotherapy, no significant differences in physical and psychosocial wellbeing were found. Physical wellbeing decreased significantly between baseline and 6- and 12-months postoperatively (p < 0.001, p = 0.035) and psychosocial wellbeing decreased significantly between baseline and 12 months postoperatively (p = 0.028) for ALND with axillary radiotherapy compared to APS alone. Arm symptoms increased significantly between baseline and 6 months and between baseline and 12 months postoperatively for APS with radiotherapy (12.71, 13.73) and for ALND with radiotherapy (13.93, 16.14), with the lowest increase in arm symptoms for ALND without radiotherapy (6.85, 7.66), compared to APS alone (p < 0.05). Conclusion: Physical and psychosocial wellbeing decreased significantly for ALND with radiotherapy compared to APS alone. Shared decision making a

Published
2024

34. Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts

Author

Cancer, MS Radiotherapie, van Geffen, E G M, Langhout, J M A, Hazen, S J A, Sluckin, T C, van Dieren, S, Beets, G L, Beets-Tan, R G H, Borstlap, W A A, Burger, J W A, Horsthuis, K, Intven, M P W, Aalbers, A G J, Havenga, K, Marinelli, A W K S, Melenhorst, J, Nederend, J, Peulen, H M U, Rutten, H J T, Schreurs, W H, Tuynman, J B, Verhoef, C, de Wilt, J H W, Marijnen, C A M, Tanis, P J, Kusters, M, On Behalf Of The Dutch Snapshot Research Group, Cancer, MS Radiotherapie, van Geffen, E G M, Langhout, J M A, Hazen, S J A, Sluckin, T C, van Dieren, S, Beets, G L, Beets-Tan, R G H, Borstlap, W A A, Burger, J W A, Horsthuis, K, Intven, M P W, Aalbers, A G J, Havenga, K, Marinelli, A W K S, Melenhorst, J, Nederend, J, Peulen, H M U, Rutten, H J T, Schreurs, W H, Tuynman, J B, Verhoef, C, de Wilt, J H W, Marijnen, C A M, Tanis, P J, Kusters, M, and On Behalf Of The Dutch Snapshot Research Group

Published
2024

35. Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer:Comparative analysis of two national cross-sectional cohorts

Author

van Geffen, E. G.M., Langhout, J. M.A., Hazen, S. J.A., Sluckin, T. C., van Dieren, S., Beets, G. L., Beets-Tan, R. G.H., Borstlap, W. A.A., Burger, J. W.A., Horsthuis, K., Intven, M. P.W., Aalbers, A. G.J., Havenga, K., Marinelli, A. W.K.S., Melenhorst, J., Nederend, J., Peulen, H. M.U., Rutten, H. J.T., Schreurs, W. H., Tuynman, J. B., Verhoef, C., de Wilt, J. H.W., Marijnen, C. A.M., Tanis, P. J., Kusters, M., van Geffen, E. G.M., Langhout, J. M.A., Hazen, S. J.A., Sluckin, T. C., van Dieren, S., Beets, G. L., Beets-Tan, R. G.H., Borstlap, W. A.A., Burger, J. W.A., Horsthuis, K., Intven, M. P.W., Aalbers, A. G.J., Havenga, K., Marinelli, A. W.K.S., Melenhorst, J., Nederend, J., Peulen, H. M.U., Rutten, H. J.T., Schreurs, W. H., Tuynman, J. B., Verhoef, C., de Wilt, J. H.W., Marijnen, C. A.M., Tanis, P. J., and Kusters, M.

Abstract

Background: In the Netherlands, use of neoadjuvant radiotherapy for rectal cancer declined after guideline revision in 2014. This decline is thought to affect the clinical nature and treatability of locally recurrent rectal cancer (LRRC). Therefore, this study compared two national cross-sectional cohorts before and after the guideline revision with the aim to determine the changes in treatment and survival of LRRC patients over time. Methods: Patients who underwent resection of primary rectal cancer in 2011 (n = 2094) and 2016 (n = 2855) from two nationwide cohorts with a 4-year follow up were included. Main outcomes included time to LRRC, synchronous metastases at time of LRRC diagnosis, intention of treatment and 2-year overall survival after LRRC. Results: Use of neoadjuvant (chemo)radiotherapy for the primary tumour decreased from 88.5% to 60.0% from 2011 to 2016. The 3-year LRRC rate was not significantly different with 5.1% in 2011 (n = 114, median time to LRRC 16 months) and 6.3% in 2016 (n = 202, median time to LRRC 16 months). Synchronous metastasis rate did not significantly differ (27.2% vs 33.7%, p = 0.257). Treatment intent of the LRRC shifted towards more curative treatment (30.4% vs. 47.0%, p = 0.009). In the curatively treated group, two-year overall survival after LRRC diagnoses increased from 47.5% to 78.7% (p = 0.013). Conclusion: Primary rectal cancer patients in 2016 were treated less often with neoadjuvant (chemo)radiotherapy, while LRRC rates remained similar. Those who developed LRRC were more often candidate for curative intent treatment compared to the 2011 cohort, and survival after curative intent treatment also improved substantially.

Published
2024

44. The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

Author

Siriwardena, A, Serrablo, A, Fretland, A, Wigmore, S, Ramia-Angel, J, Malik, H, Stattner, S, Soreide, K, Zmora, O, Meijerink, M, Kartalis, N, Lesurtel, M, Verhoef, C, Balakrishnan, A, Gruenberger, T, Jonas, E, Devar, J, Jamdar, S, Jones, R, Hilal, M, Andersson, B, Boudjema, K, Mullamitha, S, Stassen, L, Dasari, B, Frampton, A, Aldrighetti, L, Pellino, G, Buchwald, P, Gurses, B, Wasserberg, N, Gruenberger, B, Spiers, H, Jarnagin, W, Vauthey, J, Kokudo, N, Tejpar, S, Valdivieso, A, Adam, R, Hauke, L, Smith, M, Deoliveira, M, Adair, A, Gilg, S, Swijnenburg, R, Jaekers, J, Jegatheeswaran, S, Buis, C, Parks, R, Bockhorn, M, Conroy, T, Petras, P, Primavesi, F, Chan, A, Cipriani, F, Rubbia-Brandt, L, Foster, L, Abdelaal, A, Yaqub, S, Rahbari, N, Fondevila, C, Abradelo, M, Kok, N, Tejedor, L, Martinez-Baena, D, Azoulay, D, Maglione, M, Serradilla-Martin, M, Azevedo, J, Romano, F, Line, P, Forcen, T, Panis, Y, Stylianides, N, Bale, R, Quaia, E, Yassin, N, Duque, V, Espin-Basany, E, Mellenhorst, J, Rees, A, Adeyeye, A, Tuynman, J, Simillis, C, Duff, S, Wilson, R, De Nardi, P, Palmer, G, Zakaria, A, Perra, T, Porcu, A, Tamini, N, Kelly, M, Metwally, I, Morarasu, S, Carbone, F, Estaire-Gomez, M, Perez, E, Seligmann, J, Gollins, S, Braun, M, Hessheimer, A, Alonso, V, Radhakrishna, G, Alam, N, Camposorias, C, Barriuoso, J, Ross, P, Ba-Ssalamah, A, Muthu, S, Filobbos, R, Nadarajah, V, Hattab, A, Newton, C, Barker, S, Sibbald, J, Hancock, J, de Liguori Carino, N, Deshpande, R, Lancellotti, F, Paterna, S, Gutierrez-Diez, M, Artigas, C, Siriwardena A. K., Serrablo A., Fretland A. A., Wigmore S. J., Ramia-Angel J. M., Malik H. Z., Stattner S., Soreide K., Zmora O., Meijerink M., Kartalis N., Lesurtel M., Verhoef C., Balakrishnan A., Gruenberger T., Jonas E., Devar J., Jamdar S., Jones R., Hilal M. A., Andersson B., Boudjema K., Mullamitha S., Stassen L., Dasari B. V. M., Frampton A. E., Aldrighetti L., Pellino G., Buchwald P., Gurses B., Wasserberg N., Gruenberger B., Spiers H. V. M., Jarnagin W., Vauthey J. -N., Kokudo N., Tejpar S., Valdivieso A., Adam R., Hauke Lang, Smith M., deOliveira M. L., Adair A., Gilg S., Swijnenburg R. -J., Jaekers J., Jegatheeswaran S., Buis C., Parks R., Bockhorn M., Conroy T., Petras P., Primavesi F., Chan A. K. C., Cipriani F., Rubbia-Brandt L., Foster L., Abdelaal A., Yaqub S., Rahbari N., Fondevila C., Abradelo M., Kok N. F., Tejedor L., Martinez-Baena D., Azoulay D., Maglione M., Serradilla-Martin M., Azevedo J., Romano F., Line P. -D., Forcen T. A., Panis Y., Stylianides N., Bale R., Quaia E., Yassin N., Duque V., Espin-Basany E., Mellenhorst J., Rees A., Adeyeye A., Tuynman J. B., Simillis C., Duff S., Wilson R., De Nardi P., Palmer G. J., Zakaria A. D., Perra T., Porcu A., Tamini N., Kelly M. E., Metwally I., Morarasu S., Carbone F., Estaire-Gomez M., Perez E. M., Seligmann J., Gollins S., Braun M., Hessheimer A., Alonso V., Radhakrishna G., Alam N., Camposorias C., Barriuoso J., Ross P., Ba-Ssalamah A., Muthu S., Filobbos R., Nadarajah V., Hattab A., Newton C., Barker S., Sibbald J., Hancock J., de Liguori Carino N., Deshpande R., Lancellotti F., Paterna S., Gutierrez-Diez M., Artigas C., Siriwardena, A, Serrablo, A, Fretland, A, Wigmore, S, Ramia-Angel, J, Malik, H, Stattner, S, Soreide, K, Zmora, O, Meijerink, M, Kartalis, N, Lesurtel, M, Verhoef, C, Balakrishnan, A, Gruenberger, T, Jonas, E, Devar, J, Jamdar, S, Jones, R, Hilal, M, Andersson, B, Boudjema, K, Mullamitha, S, Stassen, L, Dasari, B, Frampton, A, Aldrighetti, L, Pellino, G, Buchwald, P, Gurses, B, Wasserberg, N, Gruenberger, B, Spiers, H, Jarnagin, W, Vauthey, J, Kokudo, N, Tejpar, S, Valdivieso, A, Adam, R, Hauke, L, Smith, M, Deoliveira, M, Adair, A, Gilg, S, Swijnenburg, R, Jaekers, J, Jegatheeswaran, S, Buis, C, Parks, R, Bockhorn, M, Conroy, T, Petras, P, Primavesi, F, Chan, A, Cipriani, F, Rubbia-Brandt, L, Foster, L, Abdelaal, A, Yaqub, S, Rahbari, N, Fondevila, C, Abradelo, M, Kok, N, Tejedor, L, Martinez-Baena, D, Azoulay, D, Maglione, M, Serradilla-Martin, M, Azevedo, J, Romano, F, Line, P, Forcen, T, Panis, Y, Stylianides, N, Bale, R, Quaia, E, Yassin, N, Duque, V, Espin-Basany, E, Mellenhorst, J, Rees, A, Adeyeye, A, Tuynman, J, Simillis, C, Duff, S, Wilson, R, De Nardi, P, Palmer, G, Zakaria, A, Perra, T, Porcu, A, Tamini, N, Kelly, M, Metwally, I, Morarasu, S, Carbone, F, Estaire-Gomez, M, Perez, E, Seligmann, J, Gollins, S, Braun, M, Hessheimer, A, Alonso, V, Radhakrishna, G, Alam, N, Camposorias, C, Barriuoso, J, Ross, P, Ba-Ssalamah, A, Muthu, S, Filobbos, R, Nadarajah, V, Hattab, A, Newton, C, Barker, S, Sibbald, J, Hancock, J, de Liguori Carino, N, Deshpande, R, Lancellotti, F, Paterna, S, Gutierrez-Diez, M, Artigas, C, Siriwardena A. K., Serrablo A., Fretland A. A., Wigmore S. J., Ramia-Angel J. M., Malik H. Z., Stattner S., Soreide K., Zmora O., Meijerink M., Kartalis N., Lesurtel M., Verhoef C., Balakrishnan A., Gruenberger T., Jonas E., Devar J., Jamdar S., Jones R., Hilal M. A., Andersson B., Boudjema K., Mullamitha S., Stassen L., Dasari B. V. M., Frampton A. E., Aldrighetti L., Pellino G., Buchwald P., Gurses B., Wasserberg N., Gruenberger B., Spiers H. V. M., Jarnagin W., Vauthey J. -N., Kokudo N., Tejpar S., Valdivieso A., Adam R., Hauke Lang, Smith M., deOliveira M. L., Adair A., Gilg S., Swijnenburg R. -J., Jaekers J., Jegatheeswaran S., Buis C., Parks R., Bockhorn M., Conroy T., Petras P., Primavesi F., Chan A. K. C., Cipriani F., Rubbia-Brandt L., Foster L., Abdelaal A., Yaqub S., Rahbari N., Fondevila C., Abradelo M., Kok N. F., Tejedor L., Martinez-Baena D., Azoulay D., Maglione M., Serradilla-Martin M., Azevedo J., Romano F., Line P. -D., Forcen T. A., Panis Y., Stylianides N., Bale R., Quaia E., Yassin N., Duque V., Espin-Basany E., Mellenhorst J., Rees A., Adeyeye A., Tuynman J. B., Simillis C., Duff S., Wilson R., De Nardi P., Palmer G. J., Zakaria A. D., Perra T., Porcu A., Tamini N., Kelly M. E., Metwally I., Morarasu S., Carbone F., Estaire-Gomez M., Perez E. M., Seligmann J., Gollins S., Braun M., Hessheimer A., Alonso V., Radhakrishna G., Alam N., Camposorias C., Barriuoso J., Ross P., Ba-Ssalamah A., Muthu S., Filobbos R., Nadarajah V., Hattab A., Newton C., Barker S., Sibbald J., Hancock J., de Liguori Carino N., Deshpande R., Lancellotti F., Paterna S., Gutierrez-Diez M., and Artigas C.

Abstract

Background: Contemporary management of patients with synchronous colorectal cancer and liver metastases is complex. The aim of this project was to provide a practical framework for care of patients with synchronous colorectal cancer and liver metastases with a focus on terminology, diagnosis and management. Methods: This project was a multi-organisational, multidisciplinary consensus. The consensus group produced statements which focused on terminology, diagnosis and management. Statements were refined during an online Delphi process and those with 70% agreement or above were reviewed at a final meeting. Iterations of the report were shared by electronic mail to arrive at a final agreed document comprising twelve key statements. Results: Synchronous liver metastases are those detected at the time of presentation of the primary tumour. The term “early metachronous metastases” applies to those absent at presentation but detected within 12 months of diagnosis of the primary tumour with “late metachronous metastases” applied to those detected after 12 months. Disappearing metastases applies to lesions which are no longer detectable on MR scan after systemic chemotherapy. Guidance was provided on the recommended composition of tumour boards and clinical assessment in emergency and elective settings. The consensus focused on treatment pathways including systemic chemotherapy, synchronous surgery and the staged approach with either colorectal or liver-directed surgery as first step. Management of pulmonary metastases and the role of minimally invasive surgery was discussed. Conclusions: The recommendations of this contemporary consensus provide information of practical value to clinicians managing patients with synchronous colorectal cancer and liver metastases.

Published
2023

46. Histopathological growth patterns of neuroendocrine tumor liver metastases

Author

Meyer, Y., Bohlok, A., Olthof, P., Donckier, V., Doukas, M., Lucidi, V., Vermeulen, Peter, Grunhagen, D., Verhoef, C., Surgery, and Pathology

Subjects
Cancer Research, Oncology, SDG 3 - Good Health and Well-being, Human medicine, General Medicine
Abstract

Histopathological growth patterns (HGPs) of liver metastases represent a potential biomarker for prognosis after resection. They have never been studied in neuroendocrine tumor liver metastases (NETLM). This study evaluated if distinct HGPs can be observed in resected NETLM and if they have prognostic value. Sixty-three patients who underwent resection of NETLM between 01–01-2001 and 31–12-2021 were retrospectively included. HGPs were scored on Haematoxylin&Eosin slides using light microscopy, distinguishing desmoplastic- (dHGP), pushing- (pHGP) and replacement HGP (rHGP). Average HGP scores were calculated per patient. Each patient was classified according to predominant HGP. Overall and Disease-Free Survival (OS and DFS) were evaluated through Kaplan–Meier analysis and Cox regression. Eighteen patients had predominant dHGP (29%), 33 had predominant pHGP (52%) and 11 had predominant rHGP (17%). One patient had mixed HGP (2%). Five-year OS was 76% (95%CI: 66–87%) for the overall cohort. Five-year OS was 92% (95%CI: 77–100%) for dHGP, was 73% (95%CI: 59–91%) for pHGP, 50% (95%CI: 25–100%) for rHGP. Five-year DFS was 39% (95%CI: 19–83%) for dHGP, 44% (95%CI: 27–71%) for rHGP and 50% (95%CI: 23–100%) for pHGP. There was no significant association between HGP and OS or DFS in multivariable analysis. Distinct HGPs could be identified in NETLM. In patients who underwent resection of NETLM, no association was found between HGPs and postoperative survival. Half of the patients with NETLM have a predominant pushing growth pattern, which is a rare growth pattern in liver metastases from breast and colorectal cancer.

Published
2023

47. Palliative pelvic exenteration: A systematic review of patient-centered outcomes

Author

Kroon, Hidde M., Dudi-Venkata, N.N., Bedrikovetski, S., Thomas, M.L., Kelly, M.E., Aalbers, A.G.J., Abdul Aziz, N., Abraham-Nordling, M., Akiyoshi, T., Alberda, W., Andric, M., Antoniou, A., Austin, K.K., Baker, R.P., Bali, M., Baseckas, G., Bednarski, B.K., Beets, G.L., Berg, P.L., Beynon, J., Biondo, S., Bordeianou, L., Brunner, M., Buchwald, P., Burger, J.W.A., Burling, D., Campain, N., Chan, K.K.L., Chang, G.J., Chew, M.H., C Chong, P., Christensen, H.K., Codd, M., Colquhoun, A.J., Corr, A., Coscia, M., Coyne, P.E., Creavin, B., Damjanovic, L., Daniels, I.R., Davies, M., Davies, R.J., de Wilt, J.H.W., Denost, Q., Dietz, D., Dozois, E.J., Duff, M., Eglinton, T., Enriquez-Navascues, J.M., Evans, M.D., Fearnhead, N.S., Frizelle, F.A., Garcia-Granero, E., Garcia-Sabrido, J.L., Gentilini, L., George, M.L., Glynn, R., Golda, T., Griffiths, B., Harris, D.A., Evans, M., Hagemans, J.A.W., Harji, D.P., Heriot, A.G., Hohenberger, W., Holm, T., Jenkins, J.T., Kapur, S., Kanemitsu, Y., Kelley, S.R., Keller, D.S., Kim, H., Koh, C.E., Kok, N.F.M., Kokelaar, R., Kontovounisios, C., Kusters, M., Larson, D.W., Law, W.L., Laurberg, S., Lee, P., Lydrup, M.L., Lynch, A.C., Mantyh, C., Mathis, K.L., Martling, A., Meijerink, W.J.H.J., Merkel, S., Mehta, A.M., McDermott, F.D., McGrath, J.S., Mirnezami, A., Morton, J.R., Mullaney, T.G., Mesquita-Neto, J.W., Nielsen, M.B., Nieuwenhuijzen, G.A.P., Nilsson, P.J., O'Connell, P.R., Palmer, G., Patsouras, D., Pellino, G., Poggioli, G., Quinn, M., Quyn, A., Radwan, R.W., Rasheed, S., Rasmussen, P.C., Regenbogen, S.E., Rocha, R., Rothbarth, J., Roxburgh, C., Rutten, H.J.T., Ryan, É., Sagar, P.M., Saklani, A., Schizas, A.M.P., Schwarzkopf, E., Scripcariu, V., Shaikh, I., Shida, D., Simpson, A., Smart, N.J., Smith, J.J., Solomon, M.J., Sørensen, M.M., Steele, S.R., Steffens, D., Stocchi, L., Stylianides, N.A., Tekkis, P.P., Taylor, C., Tsarkov, P., Tsukamoto, S., Turner, W.H., Tuynman, J.B., van Ramshorst, G.H., van Zoggel, D., Vasquez-Jimenez, W., Verhoef, C., Verstegen, M., Wakeman, C., Warrier, S., Wasmuth, H.H., Weiser, M.R., Wheeler, J.M.D., Wild, J., Yip, J., Winter, D.C., and Sammour, T.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results